Is this you? Create Your Porfile
Avatar

Kathleen V. Callison

Cephalon

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kathleen V. Callison is active.

Explore More

Publication

Featured researches published by Kathleen V. Callison.

Archive | 1989

Treating disorders by application of insulin-like growth factor

Michael E. Lewis; James C. Kauer; Kevin R. Smith; Kathleen V. Callison; Frank Baldino

Archive | 1990

Treating disorders by application of insulin-like growth factors and analogs

Michael E. Lewis; James C. Kauer; Kevin R. Smith; Kathleen V. Callison; Frank Baldino; Nicola Neff; Mohamed Iqbal

Clinical Endocrinology | 1998

Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment

Paul V. Carroll; Margot Umpleby; Elaine L. Alexander; Virginia A. Egel; Kathleen V. Callison; P. H. Sönksen; David Russell-Jones

Annals of the New York Academy of Sciences | 1993

The Potential of Insulin‐like Growth Factor‐I as a Therapeutic for the Treatment of Neuromuscular Disorders

Michael E. Lewis; Jeffry L. Vaught; Nicola Neff; Peter E. Grebow; Kathleen V. Callison; Erya Yu; Patricia C. Contreras; Frank Baldino

Archive | 1993

Traitement a l'aide de facteurs de croissance de type 1 proches de l'insuline et d'analogues

Michael E. Lewis; James C. Kauer; Kevin R. Smith; Kathleen V. Callison; Frank Baldino; Nicola Neff; Mohamed Iqbal

Archive | 1993

Traitement de maladies au moyen de facteurs de croissance semblables a l'insuline (igf) et d'analogues

Michael E. Lewis; James C. Kauer; Kevin R. Smith; Kathleen V. Callison; Frank Baldino; Nicola Neff; Mohamed Iqbal

Archive | 1990

Use of IGF1 or IGF2 for the manufacture of a medicament in the treatment of amyotrophic lateral sclerosis

Michael E. Lewis; James C. Kauer; Kevih R. Smith; Kathleen V. Callison; Frank Baldino

Archive | 1990

Verwendung von IGF1 oder IGF2 zur Herstellung eines Medikaments für die Behandlung von amyotrophischen Lateralsklerose Use of IGF1 or IGF2 for the preparation of a medicament for the treatment of amyotrophic lateral sclerosis

Michael E. Lewis; James C. Kauer; Kevih R. Smith; Kathleen V. Callison; Frank Baldino

Archive | 1990

Traitement de troubles par application de facteurs de croissance similaires a l'insuline et de leurs analogues

Michael E. Lewis; James C. Kauer; Kevih R. Smith; Kathleen V. Callison; Frank Baldino

Archive | 1990

Anvendelse af IGF1 eller IGF2 til fremstilling af et lægemiddeltil behandling af amyotrof, lateral sklerose

Michael E. Lewis; James C. Kauer; Kathleen V. Callison; Frank Baldino; Kevih R. Smith

Explore More

Collaboration

Dive into the Kathleen V. Callison's collaboration.

Top Co-Authors
Avatar

Frank Baldino

DuPont

View shared research outputs
Top Co-Authors
Avatar

Michael E. Lewis

DuPont

View shared research outputs
Top Co-Authors
Avatar

James C. Kauer

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Kevih R. Smith

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Kevin R. Smith

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Nicola Neff

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Mohamed Iqbal

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Elaine L. Alexander

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Erya Yu

Cephalon

View shared research outputs
Top Co-Authors
Avatar

Jeffry L. Vaught

Cephalon

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge